Radiosensitization strategy based on DNA-PK inhibition in head and neck cancer: Emphasis on human papilloma virus (HPV)

被引：0
|
作者：
Roth, Selina Moara [1 ,2 ]
Aebersold, Daniel Matthias [1 ,2 ]
Zimmer, Yitzhak [1 ,2 ]
Medova, Michaela [1 ,2 ]
机构：
[1] Bern Univ Hosp, Inselspital, Radiat Oncol, Dept BioMed Res, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：591 / 591
页数：1
相关论文
共 50 条
  • [41] Comments on: Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?
    Kannan, Raja
    ORAL ONCOLOGY, 2024, 156
  • [42] An analysis of human papilloma virus (HPV) E6 antibodies and risk of head and neck cancer: two large European studies.
    Brennan, Paul
    Johannson, Mattias
    Anantharaman, Devasena
    Pawlita, Michael
    Kreimer, Aimee
    CANCER RESEARCH, 2013, 73 (08)
  • [43] The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer (vol 106, pg 1526, 2012)
    Lajer, C. B.
    Garnaes, E.
    Friis-Hansen, L.
    Norrild, B.
    Therkildsen, M. H.
    Glud, M.
    Rossing, M.
    Lajer, H.
    Svane, D.
    Skotte, L.
    Specht, L.
    Buchwald, C.
    Nielsen, F. C.
    BRITISH JOURNAL OF CANCER, 2017, 117 (05) : 1 - 2
  • [44] Is human papiloma virus (HPV), present in patients with head and neck cancer, a prognostic factor?
    Gallegos-Hernandez, J. F.
    Flores-DeLa Torre, C.
    Hernandez-Hernandez, D. M.
    ORAL ONCOLOGY, 2009, : 164 - 164
  • [45] Prevalence and Outcomes of Human Papilloma Virus (HPV)-Associated Squamous Cell Carcinoma of the Head/Neck (SCCHN) in Elderly Patients
    Savla, D. V.
    Kann, B.
    Bakst, R.
    Posner, M.
    Genden, E.
    Gupta, V.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S248 - S248
  • [46] Prevalence and Outcomes of Human Papilloma Virus (HPV)-Associated Squamous Cell Carcinoma of the Head/Neck (SCCHN) in Elderly Patients
    Savla, D.
    Kann, B.
    Bakst, R.
    Posner, M.
    Genden, E.
    Gupta, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 496 - 496
  • [47] A POPULATION BASED STUDY OF UPTAKE OF HUMAN PAPILLOMA VIRUS (HPV) VACCINE IN CANCER SURVIVORS
    Castellino, Sharon
    Pleasant, Katherine
    Poehling, Katherine
    Tooze, Janet
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S54 - S54
  • [48] PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
    Brunner, Andra
    Rahmanto, Aldwin Suryo
    Johansson, Henrik
    Franco, Marcela
    Viiliainen, Johanna
    Gazi, Mohiuddin
    Frings, Oliver
    Fredlund, Erik
    Spruck, Charles
    Lehtio, Janne
    Rantala, Juha K.
    Larsson, Lars-Gunnar
    Sangfelt, Olle
    ELIFE, 2020, 9 : 1 - 28
  • [49] p53-dependent treatment response to DNA-PK inhibition in combination with irradiation in head and neck squamous cell carcinoma (HNSCC) models
    Hayrapetyan, Liana
    Roth, Selina M.
    Hovhannisyan, Lusine
    Medo, Matus
    Aebersold, Daniel M.
    Zimmer, Yitzhak
    Medova, Michaela
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer
    Dang, Rajan P.
    Le, Valerie H.
    Miles, Brett A.
    Teng, Marita S.
    Genden, Eric M.
    Bakst, Richard L.
    Gupta, Vishal
    Zhang, David Y.
    Demicco, Elizabeth G.
    Posner, Marshall R.
    Misiukiewicz, Krzysztof J.
    ANTICANCER RESEARCH, 2016, 36 (04) : 1703 - 1709
12345